Live Breaking News & Updates on Immune Programs Profiled

Stay updated with breaking news from Immune programs profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SystImmune, Inc. to Present New Data from Oncology Programs at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2023

/PRNewswire/ Systimmune, Inc. (SystImmune) announced today that it will present clinical data from its lead programs at the ASCO Annual Meeting 2023 in. ....

United States , Martin Olivo , Yi Zhu , Securities Exchange , Systimmune Inc , While Systimmune Inc , Presentation Details , Immune Programs Profiled , Growth Factor Receptors , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Investigational New Drug , Systimmune Inc ,